Afuco™ Anti-Human rGC ADCC Therapeutic Antibody, ADCC Enhanced

Anti-rGC ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The isolated antibody or antigen-binding portion selectively binds to an extracellular domain of a mammalian guanylyl cyclase (rGC) receptor, can be used for monitoriing the therapeutical effect of kidney-related diseases.
Supplier Creative Biolabs
Product # AFC-769CL
Pricing Inquiry
Host Human
Target rGC
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.
Feedback